1Durand ZI,Bertrand M.The value of clopidogrel versus aspirin in reducing atherothrombotic events:The CAPRIE study[J].Pharmacoeconomics,2004,22(Suppl 4):19-27.
2The CURE Investigators.Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation[J].N Engl J Med,2001,345:494-502.
3Mehta SR,Yusuf S,Peters RJG,et al.Effects of pretreatment with clopidogrel and aspirin followed by longterm therapy in patients undergoing percutaneous coronary intervention:The PCI-CURE study[J].Lancet,2004,358:527-533.
4Steinhubl SR,Berger PD,Mann JT,et al.For the CREDO Investigators.Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention:A randomized controlled trial[J].JAMA,2002,288:2411-2420.
5Michael-Ho P,Peterson ED,Wang L,et al.Incidence of death and acute myocardial infarction coronary syndrome associated with stopping clopidogrel after acute coronary syndrome[J].JAMA,2008,299(5):532-539.
6Collet JP,Montalescot G,Blanchet B,et al.Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes[J].Circulation,2004,110:2361-2367.
7Valgimigli M,Campo G,Arcozzi C,et al.Two year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein Ⅱb/Ⅲa Inhibitor Infusion in patients with myocardial infarction:Results from the STRATEGY study[J].J Am Coll Cardiol,2007,50(2):138-145.
8Collet JP,Himbert D,Steg PG.Myocardial infarction after aspirin cessation in stable coronary artery disease patients(Letter)[J].Int J Cardiol,2000,76:257-258.
9Vial JH,McLeod LJ,Roberts MS.Rebound elevation in urinary thromboxane B2 and 6-keto-PGF1 alpha exacerbation after aspirin withdrawal[J].Adv Prostaglandin Thromboxane Leukot Res,1991,21:157-160.
10Serebruany VL,Midei MG,Meilman H,et al.Rebound platelet activation after termination of prasugrel and aspirin therapy due to confirmed non-compliance in patient enrolled in the JUMBO Trial[J].Int J Clin Pract,2006,60(7):863-866.
